amgen inc (AMGN:NASDAQ GS)
Transactions by AMGEN INC (AMGN) in the last 6 months
Amgen Inc. (NasdaqGS:AMGN) entered into a definitive acquisition agreement to acquire Dezima Pharma B.V. from Forbion Capital Partners, BioGeneration Ventures Fund II, fund managed by BioGeneration Ventures B.V., New Science Ventures, LLC and others for $1.6 billion on September 16, 2015. Under the terms, Amgen Inc. will pay $300 million in cash and $1.3 billion additional payments if certain development and sales milestones are achieved. After completion Dezima Pharma ...
BioGeneration Ventures Fund II
Forbion Capital Partners
New Science Ventures, LLC
MedImmune, LLC acquired biological medicines manufacturing facility in Boulder, Colorado from Amgen Inc. (NasdaqGS:AMGN) for $14.6 million on September 9, 2015.
|AbbVie Inc||$56.04 USD||0.00|
|Allergan plc||$276.16 USD||+7.17|
|Eli Lilly & Co||$83.77 USD||-0.22|
|Medtronic PLC||$72.05 USD||0.00|
|Novo Nordisk A/S||kr357.30 DKK||-1.00|
|View Industry Companies|